Table 2.

Triggers for goals-of-care discussions for patients with DLBCL

Refractory disease 
Relapsed disease 
Declining performance status 
Organ insufficiency 
Consideration of ASCT 
Consideration of CAR T therapy 
If you “would not be surprised if the patient died within the next year.” 
Refractory disease 
Relapsed disease 
Declining performance status 
Organ insufficiency 
Consideration of ASCT 
Consideration of CAR T therapy 
If you “would not be surprised if the patient died within the next year.” 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal